Sweden’s Healthcare IT Market Enters a New Era Where Digital Maturity Alone Is No Longer Enough
Black Book Releases Sweden 2026 Digital Healthcare IT Report, Marking 17 Years of Polling and Highlighting a New Procurement Era...
Black Book Releases Sweden 2026 Digital Healthcare IT Report, Marking 17 Years of Polling and Highlighting a New Procurement Era...
The natural, functional mushroom market is experiencing rapid growth, projected to exceed USD 60 billion by 2030, driven by rising...
Joint venture executed combining Wellgistics Hub and KareRx Hub technology and operationsIntegrated platform accelerates pharmaceutical access, fulfillment, and commercializationCombined ecosystem...
First-in-human clinical trial underway to evaluate safety, tolerability and pharmacodynamic activity of HB2198 in normal healthy volunteers. A separate Phase...
Er-Kim announces exclusive partnership with LEO Pharma A/S to launch LOQTORZI® across Central and Eastern Europe, expanding access to innovative...
Recognition Follows 2025 HLTH Digital Health Award for Nociscan Award Winning AI Targets a Large and Costly Chronic Low Back...
Latest Solutions Focus on Improving AR Recovery and Denials ManagementCHICAGO, April 14, 2026 (GLOBE NEWSWIRE) -- R1 (“R1” or the...
Major paradigm shift incorporates five-year risk assessment and identifies increased-risk women beginning at age 35 BOSTON, April 14, 2026 (GLOBE...
Partnership Extends IM8’s Mission Beyond Premium Nutrition to Address Malnutrition Among the World’s Most Vulnerable Populations Long-Term Goal to Impact...
- Top-line data expected in mid-2027; Actively planning for HU6’s late-stage development in MASH - - HU6 is potential best-in-class...
DURHAM, N.C., April 14, 2026 (GLOBE NEWSWIRE) -- GeneCentric, a company making precision medicine more precise by bringing gene expression...
CARLSBAD, Calif., April 14, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL), a medical technology company pioneering AI-enabled personalized spine...
Enhancing emergency triage imaging with Nanox.ARC to improve efficiency and lower radiation dose Collaboration expands clinical evidence base of Nanox.ARC...
On track to complete 16-week, dose-finding Phase 1b study (n=240) in summer 2026 Phase 1b data will build upon Phase...
Adds dedicated business development leadership to support Tempest’s strategic prioritiesWill lead China outreach and cross-border partnership effortsTo support ongoing partnering...
Establishes framework targeting multi-product commercialization across high-growth health and wellness categories with scalable revenue potentialWoodland, CA, April 14, 2026 (GLOBE...
Positive real-world head-to-head data on GraftAssureTM assay to be presented at the 39th European Immunogenetics and Histocompatibility Conference (EFI2026), April...
SAN DIEGO, April 14, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology...
Mean time to graft reduced to 13.6 days vs. 33.2 days real-world benchmark (~20 day reduction)Median time to graft of...
Vancouver, Canada, April 14, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the "Company"), a clinical-stage biotech...